Pilot Study of Safety and Feasibility of Acquiring Hyperpolarized Imaging in Patients With Gliomas
Susan Chang
Summary
This pilot trial studies the side effects of hyperpolarized carbon C 13 pyruvate magnetic resonance imaging (MRI) in diagnosing participants with glioma. Diagnostic procedures, such as hyperpolarized carbon C 13 pyruvate MRI, may help find and diagnose glioma.
Description
PRIMARY OBJECTIVES: I. To assess the safety and feasibility of hyperpolarized 13C MR metabolic imaging as a new and unique tool for evaluating tumor burden and detecting early response to therapy in participants with glioma. II. To define the most appropriate imaging parameters for obtaining hyperpolarized 13C data from the brain, one hundred participants with evidence of residual disease from a prior MRI examination will have hyperpolarized metabolic imaging after receiving one or two injections of hyperpolarized 13 C pyruvate. For participants who are willing to receive two injections, the…
Eligibility
- Age range
- 19+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: For Participants in Cohort 1: Histologically proven glioma who have evidence of evaluable disease based on a prior magnetic resonance (MR) scan. For Participants in Cohort 2: Histologically proven glioma who will be undergoing treatment. To be included in the study all subjects must also meet the following criteria: 1. Participants must be \> 18 years old and with a life expectancy \> 12 weeks. 2. Participants must have a Karnofsky performance status of ≥ 60. 3. Participants must have adequate renal function (creatinine \< 1.5 mg/dL) before starting therapy. This tests…
Interventions
- RadiationHyperpolarized Carbon C 13 Pyruvate
Given IV
- ProcedureMagnetic Resonance Imaging
Undergo MRI
- RadiationRadiation Therapy
Undergo radiation therapy for cancer outside of this study.
- DrugChemotherapy
Undergo chemotherapy for cancer outside of this study.
Location
- University of California, San FranciscoSan Francisco, California